91722 ⎘
Ketones; Ketenes; Dimeric ketenes ; Ketonic chelates; Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA
#2COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA
#3Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia
#4species as industrial chemical feedstocks
#5COMPOSITION FOR TREATMENT, PREVENTION, OR AMELIORATION OF LYMPHEDEMA
#6Chalcone compound and preparation method thereof
#7CHALCONES AND DERIVATIVES FOR USE IN MEDICAMENTS AND NUTRACEUTICALS
#8Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia
#9Diarylalkanes as potent inhibitors of binuclear enzymes
#10Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex
#11GSK-3β inhibitors and use thereof in methods of treatment
#12SQUARYLIUM COMPOUNDS FOR USE IN DISPLAY DEVICES
#13Diarylalkanes as potent inhibitors of binuclear enzymes
#14Heat shock protein 90 inhibitors
#15Anti-fungal compounds
#16Inhibitors of bacterial RNA polymerase: arylpropanoyl, arylpropenoyl, and arylcyclopropanecarboxyl phloroglucinols
#17SHIP1 modulators and methods related thereto
#18Aspirin derivatives and uses thereof
#19Aspirin derivatives and uses thereof
#20Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease
#21Bulky ligands and metal compounds comprising bulky ligands
#22Unsaturated deoxybenzoin compounds and polymers prepared therefrom
#23O-phenyl chalcone compounds and preparation method and use thereof
#24SHIP1 modulators and methods related thereto
#25Neuroprotective polyphenol analogs
#26Diarylalkanes as potent inhibitors of binuclear enzymes
#27Aspirin derivatives and uses thereof
#28Composition for inducing differentiation into beige and brown adipocytes and method of inducing the same
#29SHIP1 MODULATORS AND METHODS RELATED THERETO
#30Monomer, hard mask composition comprising said monomer, and method for forming pattern using said hard mask composition
#31Dihydrochalcone derivatives and their use as antibiotic agents
#32Compounds for use as inhibitors of alternative oxidase or cytochrome BC1 complex
#33Complex of garcinol, cyclodextrin and method thereof
#34Diarylalkanes as potent inhibitors of binuclear enzymes
#35Composition for treating diabetes and metabolic diseases and a preparation method thereof
#36Composition for treating atherosclerosis and a preparation method thereof
#37POLYPHENOL ANALOGS TO TREAT ISCHEMIA
#38NEUROPROTECTIVE POLYPHENOL ANALOGS
#39Methods and compositions for treating neurodegenerative diseases
#40Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
#41Aspirin derivatives and uses thereof
#42Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient
#43Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's
#44Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
#45Method for preparing 5-haloalkyl-4, 5-dihydroisoxazole derivatives
#46COMPOSITION FOR TREATING ATHEROSCLEROSIS AND A PREPARATION METHOD THEREOF
#47Conjugated aromatic compound, optical material, and optical element
#48Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds
#49METHOD FOR PREPARING 5-HALOALKYL-4, 5-DIHYDROISOXAZOLE DERIVATIVES
#50Antibacterial agents and methods of use thereof
#51Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
#52COMPLEX OF GARCINOL, CYCLODEXTRIN AND METHOD THEREOF
#53Composition comprising the extract of Bunge or the compounds isolated from the same for preventing and treating lipid metabolism disorder
#54Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
#55Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#56ISOFLAVONE METABOLITES
#57Diarylalkanes as potent inhibitors of binuclear enzymes
#58Cyanopyridine antibacterial agents and methods of use thereof
#59Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
#60Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound and method for production of isoxazoline compound
#61Alpha-hydroxyketones
#62Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds
#634-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof
#64Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#65Cycloalkylidene compounds as modulators of estrogen receptor
#66Chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof
#67Method of producing diol, polydiol, secondary alcohol or diketone compound
#68SUBSTITUTED HYDROXYACETOPHENONE DERIVATIVES
#69Isoflavone metabolites
#70Compounds for the Treatment of Non-Autoimmune Type 2 Diabetes Mellitus and/or Syndrome X
#71COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
#72Novel Chalcone Derivatives With Antimitotic Activity
#73TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
#74Use of compounds and compositions for the treatment of amyloid diseases
#75Agent for strengthening calcium containing tissue and use thereof
#76Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
#771-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
#78Mono, di and tri cyclic compounds useful for lowering IgE concentrations
#792-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour
#80Use of 4-hydroxychalcone derivatives for masking an unpleasant taste
#81Diarylalkanes as potent inhibitors of binuclear enzymes
#82ISOFLAVONE METABOLITES
#83Cyanopyridine antibacterial agents
#84Cycloalkylidene compounds as modulators of estrogen receptor
#85Cycloalkylidene compounds as modulators of estrogen receptor
#86Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
#87Chalcone compounds
#884-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof
#89Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
#901,3-Bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
#91Mono di & tri cyclic compounds useful for lowering IgE concentrations
#92Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
#93Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
#94Tricyclic steroid hormone nuclear receptor modulators
#95Diarylalkanes as potent inhibitors of binuclear enzymes
#96Isoflavone metabolites
#97Calcium-containing tissue strengthening agents and use thereof
#98Clusianon isomers and use thereof
#996-Hydroxy isoflavones derivatives and medicaments involving same